NEXGEL INC (NXGL:NASDAQ)
$0.6001 -0.0009 (-0.1498%)
Analysed NEXGEL INC (NXGL:NASDAQ) News Sources
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
17-04-2026
yahoo.com
NEXGEL, Inc. Q4 2025 Earnings Call Summary
21-04-2026
moby.co
Celularity Announces Closing of Transaction with NexGel
21-04-2026
yahoo.com
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
21-04-2026
yahoo.com
NEXGEL Appoints Ian Blackman as Chief Financial Officer
27-04-2026
yahoo.com
NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors
06-05-2026
yahoo.com
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
12-05-2026
yahoo.com
NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical
13-05-2026
yahoo.com
Nexgel (NXGL) Q1 2026 Earnings Transcript
15-05-2026
fool.com
NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration
19-05-2026
yahoo.com
What is the current price of NEXGEL INC (NXGL:NASDAQ)?
The current price of NEXGEL INC (NXGL:NASDAQ) is $0.6001.
NEXGEL INC (NXGL:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEXGEL INC (NXGL:NASDAQ) since the previous trading day is $-0.0009.
NEXGEL INC (NXGL:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEXGEL INC (NXGL:NASDAQ) since the previous trading day is -0.1498%.
What is the most recent average sentiment score for NEXGEL INC (NXGL:NASDAQ)?
The most recent average sentiment score for NEXGEL INC (NXGL:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for NEXGEL INC (NXGL:NASDAQ)?
The most recent sentiment for NEXGEL INC (NXGL:NASDAQ) is .
SEC-8K** Filing Available For NEXGEL INC (NXGL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.